- Home
- DTSQ vs MDXH Comparison
DTSQ vs MDXH Comparison
Compare DTSQ & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSQ
- MDXH
- Stock Information
- Founded
- DTSQ 2022
- MDXH 2003
- Country
- DTSQ United States
- MDXH Belgium
- Employees
- DTSQ N/A
- MDXH N/A
- Industry
- DTSQ
- MDXH
- Sector
- DTSQ
- MDXH
- Exchange
- DTSQ NYSE
- MDXH Nasdaq
- Market Cap
- DTSQ 89.0M
- MDXH 100.5M
- IPO Year
- DTSQ 2024
- MDXH 2021
- Fundamental
- Price
- DTSQ $10.03
- MDXH $1.77
- Analyst Decision
- DTSQ
- MDXH Strong Buy
- Analyst Count
- DTSQ 0
- MDXH 2
- Target Price
- DTSQ N/A
- MDXH $7.00
- AVG Volume (30 Days)
- DTSQ 5.5K
- MDXH 98.8K
- Earning Date
- DTSQ 01-01-0001
- MDXH 11-06-2024
- Dividend Yield
- DTSQ N/A
- MDXH N/A
- EPS Growth
- DTSQ N/A
- MDXH N/A
- EPS
- DTSQ 0.24
- MDXH N/A
- Revenue
- DTSQ N/A
- MDXH $84,708,000.00
- Revenue This Year
- DTSQ N/A
- MDXH $26.39
- Revenue Next Year
- DTSQ N/A
- MDXH $18.68
- P/E Ratio
- DTSQ $42.61
- MDXH N/A
- Revenue Growth
- DTSQ N/A
- MDXH 33.01
- 52 Week Low
- DTSQ $9.96
- MDXH $0.35
- 52 Week High
- DTSQ $10.06
- MDXH $4.64
- Technical
- Relative Strength Index (RSI)
- DTSQ N/A
- MDXH 26.20
- Support Level
- DTSQ N/A
- MDXH $1.62
- Resistance Level
- DTSQ N/A
- MDXH $2.24
- Average True Range (ATR)
- DTSQ 0.00
- MDXH 0.13
- MACD
- DTSQ 0.00
- MDXH -0.01
- Stochastic Oscillator
- DTSQ 0.00
- MDXH 28.57
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.